Register for
e-Notifications of when site is updated.
Addiction Treatment Forum is made possible by an unrestricted educational grant from Covidien Mallinckrodt, St. Louis, MO, a manufacturer of methadone and naltrexone. Addiction Treatment Forum is produced by an independent medical communications agency. Commercial advertising is not accepted. See also, Contact Information, Terms of Use, and Privacy Policy.
© Addiction Treatment Forum Published by Clinco Communications, Inc. P.O. Box 685 Mundelein, IL 60060 Phone/Fax: 847-392-3937 E-mail to: Feedback@ATForum.com |
Addiction Treatment Forum reports on substance abuse and addiction therapies, research, news, and events of interest to both healthcare professionals and patients with a focus on methadone maintenance for opioid-addiction treatment. Here's What's New...Winter 2008 AT Forum Newsletter (Vol. 17, #1)
Go to Current Newsletter PDF (HTML Version available) New Issue : March 2008 Europad JournalHeroin Addiction and Related Clinical Problems. 2008(March), Vol. 10, No. 1
AT Forum readers interested in pain and its treatment should visit our affiliate website, Pain Treatment Topics, at Pain-Topics.org. This is a non-commercial, open-access resource for healthcare professionals. It provides evidence-based clinical news, information, research, and education on the causes and treatment of pain, including acute, chronic, and terminal (end-of-life) pain conditions. A special section examines the interface of pain and addiction.
|
| © Addiction Treatment Forum | Updated May 7, 2008 |

After publishing 56 issues of AT Forum, we have redesigned the newsletter to make it more visually appealing and easier to read. We will strive to diversify our topics, keeping in mind the varied backgrounds of our 11,000-plus readers, among them patients, clinic staff members, researchers, key opinion leaders, and government officials.
Over the next few issues we will celebrate our 15th anniversary by reflecting on the past 40-plus years of methadone maintenance treatment (MMT), current issues in MMT, and thoughts about the future of MMT as it evolves into broader Opioid Treatment Programs (OTPs).